# N-Acetylcysteine in Severe Acute Alcoholic Hepatitis

> **NCT00962442** · PHASE3 · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 44 (actual)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** N-Acetylcysteine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00962442
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2009-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962442, "N-Acetylcysteine in Severe Acute Alcoholic Hepatitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00962442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*